Douglas John Karas - Net Worth and Insider Trading

Douglas John Karas Net Worth

The estimated net worth of Douglas John Karas is at least $5,854 dollars as of 2024-05-28. Douglas John Karas is the Director of Nascent Biotech Inc and owns about 60,000 shares of Nascent Biotech Inc (NBIO) stock worth over $5,854. Details can be seen in Douglas John Karas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas John Karas has not made any transactions after 2015-04-03 and currently still holds the listed stock(s).

Transaction Summary of Douglas John Karas

To

Douglas John Karas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas John Karas owns 1 companies in total, including Nascent Biotech Inc (NBIO) .

Click here to see the complete history of Douglas John Karas’s form 4 insider trades.

Insider Ownership Summary of Douglas John Karas

Ticker Comapny Transaction Date Type of Owner
NBIO Nascent Biotech Inc 2015-04-03 director

Douglas John Karas Latest Holdings Summary

Douglas John Karas currently owns a total of 1 stock. Douglas John Karas owns 60,000 shares of Nascent Biotech Inc (NBIO) as of April 3, 2015, with a value of $5,854.

Latest Holdings of Douglas John Karas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBIO Nascent Biotech Inc 2015-04-03 60,000 0.10 5,854

Holding Weightings of Douglas John Karas


Douglas John Karas Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas John Karas has made a total of 0 transactions in Nascent Biotech Inc (NBIO) over the past 5 years. The most-recent trade in Nascent Biotech Inc is the acquisition of 10,000 shares on April 3, 2015, which cost Douglas John Karas around $10,000.

Insider Trading History of Douglas John Karas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas John Karas Trading Performance

GuruFocus tracks the stock performance after each of Douglas John Karas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas John Karas is 38.1%. GuruFocus also compares Douglas John Karas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas John Karas within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas John Karas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas John Karas

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 26.67
Relative Return to S&P 500(%) 24.67

Douglas John Karas Ownership Network

Ownership Network List of Douglas John Karas

No Data

Ownership Network Relation of Douglas John Karas


Douglas John Karas Owned Company Details

What does Nascent Biotech Inc do?

Who are the key executives at Nascent Biotech Inc?

Douglas John Karas is the director of Nascent Biotech Inc. Other key executives at Nascent Biotech Inc include director & CFO Lowell Thomas Holden , director & President Sean Carrick , and director & Senior VP Business Development Brandon Price .

Nascent Biotech Inc (NBIO) Insider Trades Summary

Over the past 18 months, Douglas John Karas made no insider transaction in Nascent Biotech Inc (NBIO). Other recent insider transactions involving Nascent Biotech Inc (NBIO) include a net purchase of 130,000 shares made by Lowell Thomas Holden ,

In summary, during the past 3 months, insiders sold 0 shares of Nascent Biotech Inc (NBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nascent Biotech Inc (NBIO) were sold and 130,000 shares were bought by its insiders, resulting in a net purchase of 130,000 shares.

Nascent Biotech Inc (NBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nascent Biotech Inc Insider Transactions

No Available Data

Douglas John Karas Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas John Karas. You might contact Douglas John Karas via mailing address: 631 Us Hwy 1, Suite 407, North Palm Beach Fl 33408.

Discussions on Douglas John Karas

No discussions yet.